tbuckley/cabot-search huggingface dataset:
Acute Myeloid Leukemia (AML) Risk Stratification Using the European Leukemianet 2022 Classification in a Real-Life Cohort of Patients from Sardinia, Italy
Authors: Giovanna Piras, Antonella Uras, Antonella Cucca, Maria Monne, Alessandro Costa, Sabrina Chiriu, Francesco Longu, Marco Murineddu, Luigi Benedetto Arru, Alessandro Bianchi, Anna Calvisi, Alessandra Di Francesco, Alessandro Murgia, Francesca Cambosu, Mauro P Flagiello, Maria Antonia Isoni, Giovanni Caocci, Claudio Fozza, Angelo D. Palmas
Journal: Blood (2022)
Clinical Outcomes of Patients with Breast Implant- Associated Anaplastic Large- Cell Lymphoma (BIA-ALCL) Treated with Chemotherapy and Brentuximab Vedotin
Authors: Alexandra Elias, Rishab Prakash, Loretta J. Nastoupil, Nathan H. Fowler, Sairah Ahmed, Ranjit Nair, Luis Enrique Malpica Castillo, Bouthaina S. Dabaja, Jie Xu, Jeffrey Medeiros, John Stewart, Wei Wang, Chelsea C. Pinnix, Kelly Hunt, Mark W Clemens, Roberto N. Miranda, Swaminathan P. Iyer
Journal: Blood (2022)
Updated Safety and Efficacy of REGN5458, a BCMAxCD3 Bispecific Antibody, Treatment for Relapsed/Refractory Multiple Myeloma: A Phase 1/2 First-in-Human Study
Authors: Naresh Bumma, Joshua Richter, Jason Brayer, Jeffrey A. Zonder, Madhav Dhodapkar, Mansi R. Shah, James E. Hoffman, Raya Mawad, Joseph J. Maly, Suzanne Lentzsch, Attaya Suvannasankha, Pourab Roy, Jyotirmoy Dey, Dhruti Chokshi, Anita Boyapati, Jenn Visich, Yariv Houvras, Karen Rodriguez Lorenc, Glenn S. Kroog, Sundar Jagannath
Journal: Blood (2022)
Decreased Embryonic Splicing Repressor Expression Enhances Splicing Modulator Sensitivity in Pediatric Acute Myeloid Leukemia Stem Cells
Authors: Inge Van Der Werf, Kathleen Steel, Phoebe Mondala, Larissa Balaian, Jacqueline Cloos, Gertjan J.L. Kaspers, James La Clair, Peggy Wentworth, Kathleen Fisch, Leslie Crews, Thomas Whisenant, Michael Burkart, Mary Donohoe, Catriona Jamieson
Journal: Blood (2022)
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura: Real-World Multicenter Data on Re-Administration and Plasma Exchange Free Treatment
Authors: Eleni Gavriilaki, Evdoxia Koravou, Sotiria Dimou-Mpesikli, Emmanouil Nikolousis, Anastasia Banti, Charalampos Pontikoglou, Christina Kalpadakis, Aikaterini Bitsani, Iliana Tassi, Tasoula Touloumenidou, Thomas Chatzikonstantinou, Maria Papathanassiou, Antonia Syrigou, Eleutheria Ztriva, Georgia Kaiafa, Eudokia Mandala, Zois Mellios, Dimitrios Karakasis, Alexandra Kourakli, Argyris Symeonidis, Eleni Kapsali, Eleni Papadaki, Chrysavgi Lalayanni, Ioanna Sakellari
Journal: Blood (2022)
Silent Cerebral Infarction during Immune TTP Remission - Prevalence, Predictors and Impact on Cognition
Authors: Jia Yu, Jenna Brown, Eli Salzberg, Aria Wei, Gloria Gerber, Xiang-Zuo Pan, Alison R. Moliterno, MIchael B. Streiff, Peggy Kraus, Claire Logue, Jennifer Yui, Rakhi P.P. Naik, Hira Latif, Sophie M. Lanzkron, Evan M. Braunstein, Robert Brodsky, Michael R. DeBaun, Doris Lin, Shruti Chaturvedi
Journal: Blood (2022)
High Deliverability of a Midostaurin Triplet Regimen Incorporating Venetoclax and Low Dose Cytarabine in Non-Adverse Cytogenetic Risk Acute Myeloid Leukaemia: A Sub-Analysis of the Australasian Leukaemia Lymphoma Group (ALLG) Intervene Study
Authors: Chong Chyn Chua, Natasha S Anstee, Anoop Kumar Enjeti, Devendra Hiwase, Paula Marlton, Ashish Bajel, Shuh Ying Tan, Edward S. Morris, Chun-Kei-Kris Ma, Carolyn Grove, Julian Cooney, Ashanka Beligaswatte, Rachel M Koldej, Stephen B Ting, Travis Perera, Amanda Johnston, John Reynolds, David Ritchie, Andrew H Wei
Journal: Blood (2022)
Ultra-Sensitive Next-Generation Sequencing Establishes the Prognostic Value of Very Low MRD in Adults with Acute Lymphoblastic Leukemia Undergoing Hematopoietic Cell Transplantation
Authors: Emily C. Liang, Simone E. Dekker, Jean M.G. Sabile, Stefan Torelli, Amy Zhang, Katharine Miller, Parveen Shiraz, Brandon Hayes-Lattin, Jessica Leonard, Lori Muffly
Journal: Blood (2022)
Prolonged Maintenance of <i>Ex Vivo</i> Functional Vk*MYC Multiple Myeloma Cells Allows for <i>in Vitro</i> Manipulation and Subsequent <i>In Vivo</i> Analysis
Authors: Frances E Lock, Afsaneh Panahi, Ariene Cabantog, Lorenzo Lindo, Daniel Waller, Kevin Hay, Marta Chesi, Arefeh Rouhi, Florian Kuchenbauer
Journal: Blood (2022)
The Combination of Navitoclax and Ruxolitinib in JAK Inhibitor-Naïve Patients with Myelofibrosis Mediates Responses Suggestive of Disease Modification
Authors: Francesco Passamonti, James M. Foran, Anand Tandra, Valerio De Stefano, Maria Laura Fox, Ahmad H. Mattour, Mary Frances McMullin, Andrew Charles Perkins, Gabriela Rodríguez-Macias, Hassan Sibai, Qin Qin, Yan Sun, Jalaja Potluri, Jason Harb, Jonathan How
Journal: Blood (2022)
Type 2 but Not Type 1 Calreticulin Mutants Exhibit Loss of Chaperone Function Due to C-Terminal Structural Interference, and Bind to Wild Type Calreticulin in a Dominant Negative Manner
Authors: Nicole S Arellano, Jacqueline Gomez, Harrison S Greenbaum, Michele Ciboddo, Deborah Rodriguez, Amy K Chen, Lulu Allie, Alex Rosencrance, Shannon Elf
Journal: Blood (2022)
Machine Learning Approaches Incorporating High-Dimensional Longitudinal Data Improve the Prediction of Survival after Allogeneic Hematopoietic Cell Transplantation
Authors: Yiwang Zhou, Jesse Smith, Dinesh Keerthi, Suraj Sarvode Mothi, David C. Shyr, Barbara Spitzer, Avijit Chatterjee, Subrata Chatterjee, Swati Naik, Li Tang, Akshay Sharma
Journal: Blood (2022)
Rapid Clearance of Vector Following AAV-Mediated FVIII Gene Transfer in the Phase I/II Trial of SPK-8011 in People with Hemophilia A
Authors: Huyen Tran, M. Elaine Eyster, Stacy E. Croteau, Margaret V. Ragni, Benjamin J. Samelson-Jones, Spencer Sullivan, John E.J. Rasko, Kristen Jaworski, Amy MacDougall, Savina Jaeger, Magdalena Hofer, Charlie Li, Federico Mingozzi, Tiffany Chang, Gallia Levy
Journal: Blood (2022)
Antigen Directed Therapy Pre-Transplant Confers Superior Post-Transplant Survival Outcome Compared to Conventional Chemotherapy in Pediatric Patients with Relapsed and Refractory B-ALL
Authors: Jessica Stiefel, Allyson M. Flower, Marissa Botwinick, Maegan Ford, Alycia Foti, Mital Gandhi, Justin Slovin, Elana Smilow, Ashley Bowers, Hannah Karpel, Leya Y Schwartz, Ellen Fraint, Lisa M. Gennarini, Sharon L. Gardner, Elizabeth A. Raetz, Niketa C. Shah, Jing Chen, Jennifer Krajewski, Nobuko Hijiya, Prakash Satwani, Jessica C Hochberg, Audrey Mauguen, Kevin J. Curran, Maria Luisa Sulis
Journal: Blood (2022)
Phase 1 Study of CART-Ddbcma for the Treatment of Subjects with Relapsed and /or Refractory Multiple Myeloma
Authors: Matthew Frigault, Jacalyn Rosenblatt, Binod Dhakal, Noopur Raje, Daniella Cook, Mahmoud R. Gaballa, Estelle Emmanuel-Alejandro, Danielle Nissen, Christine Cornwell, Kamalika Banerjee, Anand Rotte, Christopher R. Heery, David Avigan, Andrzej Jakubowiak, Michael R. Bishop
Journal: Blood (2022)
Phase 1b Trial of Cereblon-Modulating Agents Iberdomide and CC-99282 Plus R-CHOP in Previously Untreated Aggressive B-Cell Lymphoma
Authors: Jason Westin, Alejandro Martín García-Sancho, Marc Hoffmann, Theodoros P. Vassilakopoulos, Su-Peng Yeh, Argyrios Gkasiamis, Poliana Patah, Arpankumar Patel, Ju Li, Grzegorz S. Nowakowski
Journal: Blood (2022)
Cardiovascular Complications of CD 19 Chimeric Antigen Receptor-T Cell Therapy: A Systematic Review
Authors: Moazzam Shahzad, Farrukh Munir, Junaid Khan, Muhammad Fareed Khalid, Sakina Abbas, Hafiza Wajeeha Javaid, Suneeba Javed Chattha, Mamoon Ahmed, Muhammad Salman Faisal, Iqra Anwar, Sibgha Gull Chaudhary, Muhammad Umair Mushtaq
Journal: Blood (2022)
Defining Clinical and Molecular Biomarkers for Venetoclax-Based Drug Combinations to Augment AML Therapy
Authors: Christopher A. Eide, Stephen E. Kurtz, Andy Kaempf, Nicola Long, Sunil K Joshi, Tamilla Nechiporuk, Ariane Huang, Charles Dibb, Daniel Bottomly, Shannon K. McWeeney, Bill H. Chang, Brian J. Druker, Jeffrey W. Tyner
Journal: Blood (2022)
Durability of Bleeding Protection and Factor IX Activity Levels Are Demonstrated in Individuals with and without Adeno-Associated Virus Serotype 5 Neutralizing Antibodies (Titers &amp;lt;1:700) with Comparable Safety in the Phase 3 HOPE-B Clinical Trial of Etranacogene Dezaparvovec Gene Therapy for Hemophilia B
Authors: Steven W. Pipe, Frank W.G. Leebeek, Michael Recht, Nigel S. Key, Susan Lattimore, Giancarlo Castaman, David Cooper, Stephanie Verweij, Ricardo Dolmetsch, Jacqueline Tarrant, Yanyan Li, Paul E. Monahan, Wolfgang A. Miesbach
Journal: Blood (2022)
Molecular Landscape of Primary Refractory DLBCL
Authors: Allison M. Bock, Kerstin Wenzl, Matthew E. Stokes, Joseph P. Novak, Melissa A. Hopper, Jordan E. Krull, Abigail Dropik, Vivekananda Sarangi, Maria Ortiz, Nicholas Stong, C. Chris Huang, Matthew J. Maurer, Rebecca L. King, Richard Curtis Godby, Umar Farooq, Yucai Wang, Stephen M. Ansell, Thomas M. Habermann, James R. Cerhan, Anita K. Gandhi, Grzegorz (Greg) Nowakowski, Anne J. Novak
Journal: Blood (2022)
Multiomic Single-Cell Sequencing of Mixed Phenotypic Acute Leukemia (MPAL) Reveals Complex Immunophenotypic, Transcriptional, and Genetic Heterogeneity
Authors: Cheryl Peretz, Vanessa E. Kennedy, Anushka Walia, Cyrille Delley, Andrew Koh, Elaine Tran, Iain Clark, Corey Hayford, Yi Xue, Chris D'Amato, Kristina Fontanez, Ritu P. Roy, Adam Olshen, Aaron C. Logan, Alexander E. Perl, Adam Abate, Catherine Smith
Journal: Blood (2022)
Isatuximab Plus Pomalidomide/Low-Dose Dexamethasone Versus Pomalidomide/Low-Dose Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma (ICARIA-MM): Characterization of Subsequent Antimyeloma Therapies
Authors: Paul G. Richardson, Aurore Perrot, Jesús San-Miguel, Meral Beksac, Ivan Spicka, Xavier Leleu, Fredrik Schjesvold, Philippe Moreau, Meletios A. Dimopoulos, Jeffrey SY Huang, Jiri Minarik, Michele Cavo, H. Miles Prince, Sandrine Macé, Laure Malinge, Franck Dubin, Mony Morisse, Kenneth C. Anderson
Journal: Blood (2022)
Risk Factors, Prevalence, and Outcomes of Invasive Fungal Disease Post Cellular Therapies: A Real-World Analysis
Authors: Eleni Gavriilaki, Panagiotis Dolgyras, Sotiria Dimou-Mpesikli, Aikaterini Poulopoulou, Christos Demosthenous, Evangelia Zachrou, Panagiotis Siasios, Despina Mallouri, Anna Vardi, Zoi Bousiou, Alkistis Panteliadou, Marianna Masmanidou, Chrysavgi Lalayanni, Evangelia Yannaki, Damianos Sotiropoulos, Achilles Anagnostopoulos, Timoleon Achilleas Vyzantiadis, Ioanna Sakellari
Journal: Blood (2022)
Detecting the Unusual without Compromising Diagnostic Accuracy - a Prospective WGS/Wts Pilot Study in Acute Leukemias Provided Additional Information for Diagnosis, Prognosis and Treatment
Authors: Manja Meggendorfer, Marietta Truger, Wencke Walter, Constance Baer, Stephan Hutter, Niroshan Nadarajah, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach
Journal: Blood (2022)
8-Day Versus 12-Day Manufactured LV20.19 CAR T-Cells for B-Cell Non-Hodgkin Lymphoma
Authors: Nirav N. Shah, Fateeha Furqan, Aniko Szabo, Jessica Neumann, Walter L. Longo, Parameswaran Hari, Dina Schneider, Bryon Johnson, Timothy S. Fenske, Mehdi Hamadani
Journal: Blood (2022)
Arcch: Improving the Performance of Clonal Hematopoiesis Variant Calling and Interpretation Using a Consensus Based Approach
Authors: Evelyn L Schmidt, Irenaeus C.C. Chan, Alex Panchot, Brian Wiley, Jie Liu, Lea Moukarzel, Yiwen Zhang, Daniel C. Link, Konrad Stopsack, Kelly L Bolton
Journal: Blood (2022)
Graft-Versus-Host Disease Induces Immune Dysregulation through Irreversible Damage to Specialized Immune-Interacting Fibroblastic Stromal Cells in Secondary Lymphoid Organs
Authors: Leolene Carrington, Shovik Bandyopadhyay, Katlyn Lederer, Samantha Kelly, Ashley Vanderbeck, Gloria Jih, Frederick Allen, Daniela Gómez Atria, Anneka Allman, Eric Perkey, Kai Tan, Norbert Pardi, Burkhard Ludewig, Ronjon Chakraverty, Ivan Maillard
Journal: Blood (2022)
Bortezomib Induced Peripheral and Severe Autonomic Neuropathy Characterized By Dizziness, Orthostatic Hypotension, and Weight Loss
Authors: Anand P. Jillella, Irina Shishkina, Gita Giddens, Courtney Corley, Kimberly Green, Rachel Ashley, Megan Johnson, Laura Walker, Sarah Jimenez, Locke J. Bryan, Ayushi Chauhan, Amany R. Keruakous, Molly James, Mohammad A.H. Mian, Danielle Bradshaw, Ravindra Kolhe, Vamsi K. Kota
Journal: Blood (2022)
Idecabtagene Vicleucel (Ide-cel) Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Who Have Received a Prior BCMA-Targeted Therapy: Real World, Multi-Institutional Experience
Authors: Christopher J. Ferreri, Michelle A.T. Hildebrandt, Hamza Hashmi, Leyla O. Shune, Joseph P. McGuirk, Douglas W. Sborov, Charlotte B Wagner, M. Hakan Kocoglu, Shebli Atrash, Peter M. Voorhees, Jack Khouri, Danai Dima, Aimaz Afrough, Aishwarya Sannareddy, Gary Simmons, James Davis, Nilesh Kalariya, Lauren C. Peres, Melissa Alsina, Frederick L. Locke, Surbhi Sidana, Doris K. Hansen, Krina Patel, Omar Alexis Castaneda Puglianini
Journal: Blood (2022)
Development of a Standardized, DNA-Based Next Generation Sequencing Assay for Assessment of Measurable Residual Disease (MRD) in Acute Myeloid Leukemia (AML) As the Primary Endpoint in the Agility Study
Authors: Luis A. Carvajal, Tressa Hood, Yana Bevan, Richard Dillon, Nicola Potter, Ian Thomas, Sean Johnson, Jad Othman, Amanda Gilkes, Nigel H. Russell, Adam Sikorski, Pete Ellis, Giovanni Marsico, Greg Jones, Crystal MacKenzie, Zung To, Jorge DiMartino, Pavan Kumar
Journal: Blood (2022)
Single-Cell Multi-Omics Reveal Longitudinal Dynamics of Clonal Architecture and Microenvironment Interactions in Relapsed-Refractory Myeloma
Authors: Alexandra M. Poos, Nina Prokoph, Moritz J. Przybilla, Jan-Philipp Mallm, Simon Steiger, Isabelle Lander, Lukas John, Stephan M Tirier, Katharina Bauer, Anja Baumann, Umair Munawar, Leo Rasche, Martin Kortuem, Nicola Giesen, Stefanie Huhn, Carsten Mueller-Tidow, Hartmut Goldschmidt, Oliver Stegle, Marc S Raab, Karsten Rippe, Niels Weinhold
Journal: Blood (2022)
An Open-Label, First-in-Human, Dose-Escalation Study of SAR443579 Administered As Single Agent By Intravenous Infusion in Patients with Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-Cell Acute Lymphoblastic Leukemia (B-ALL) or High-Risk Myelodysplasia (HR-MDS)
Authors: Anthony S. Stein, Ashish Bajel, Shaun Fleming, Mojca Jongen-Lavrencic, Sylvain Garciaz, Abhishek Maiti, Nicolas Boissel, Stephane De Botton, Gerwin A. Huls, David C. de Leeuw, David Avigan, Kyle Jensen, Brigitte Demers, Timothy Wagenaar, Gu Mi, Samira Ziti-Ljajic, Dobrin Draganov, Giovanni Abbadessa, Andrew H Wei
Journal: Blood (2022)
Fructose Treatment Targets Myeloid Leukemogenesis in IDH2 Mutants By Exhausting Alpha-Ketoglutarate Pools
Authors: Angela Maria Savino, Briana Turner, Sangmoo Jeong, Tanya Schild, Xuejing Yang, Hanzhi Luo, Rachel Chirayil, Quinlan Cullen, Mandy Chan, Grace Han, Kathryn Chang, Sudha Janaki Raman, Justin R Cross, Kayvan Keshari, Michael G Kharas
Journal: Blood (2022)
Bodyweight and Absolute Lymphocyte Count Based Dosing of Rabbit Anti-Thymocyte Globulin Results in Early CD4+ Immune Reconstitution in Patients with Inborn Errors of Metabolism Undergoing Umbilical Cord Blood Transplantation
Authors: Daniel Drozdov, Susie L. Long, Ashish O. Gupta, Troy C. Lund, Jaap Jan Boelens, Paul J. Orchard
Journal: Blood (2022)
Dysfunctional Hyper-Expanded Clonotypes and Lack of TCR Clonal Replacement Predict Resistance to T Cell Engagers in Multiple Myeloma
Authors: Paola Neri, Sungwoo Ahn, Holly Lee, Noemie Leblay, Mirco Friedrich, Ranjan Maity, Rémi Tilmont, Elie Barakat, Marc S Raab, Nizar Jacques Bahlis
Journal: Blood (2022)
Successful Use of Granulocyte Transfusion Therapy As a Bridge to Hematopoietic Stem Cell Transplant in a Child with Aplastic Anemia and Refractory Perirectal Abscess
Authors: Mary Dang, Beenish Rubbab, Jeannie Kwon, Daniel Noland, Paul Sue, Kathryn E. Dickerson
Journal: Blood (2022)
Treatment of Individuals with Severe Sickle Cell Disease with OTQ923, an Autologous, <i>Ex Vivo</i>, CRISPR/Cas9-Edited, CD34+ Hematopoietic Stem and Progenitor Cell Product, Leads to Durable Engraftment and Fetal Hemoglobin Induction
Authors: Akshay Sharma, Jaap Jan Boelens, Maria I. Cancio, Jane Hankins, Prafulla A Bhad, Andrew Lewandowski, Xiaojun Zhao, Shripad Chitnis, Radhika Peddinti, Yan Zheng, Neena Kapoor, Fabio Ciceri, Jianping Yuan, Vionnie W. Yu, Susan C. Stevenson, Serena De Vita, James LaBelle
Journal: Blood (2022)
Abrogation of Immune Effector Cell Neurotoxicity Syndrome (ICANS) By Rimiducid (RIM) in Patients Treated with CD19-Specific Chimeric Antigen Receptor Modified T-Cells (CAR-T) Engineered with an Inducible Caspase 9 (iC9 CAR.19)-Clinical and Pharmacodynamic Correlates
Authors: Matthew C. Foster, Barbara Savoldo, Winnie Lau, Clio Rubinos, Natalie S. Grover, Paul M. Armistead, James M. Coghill, Katarzyna Joanna Jamieson, Robert Hagan, J. Kaitlin Morrison, Faith Brianne Buchanan, Catherine Joyce Arago Cheng, Anastasia Ivanova, Tammy Cavallo, John West, Megan Gonzalez, Jonathan S. Serody, Gianpietro Dotti
Journal: Blood (2022)
Adaptive Routes of Hematopoietic Stem Cell Differentiation to Disease Conditions and Age in Gene Therapy Patients
Authors: Andrea Calabria, Giulio Spinozzi, Daniela Cesana, Fabrizio Benedicenti, Giulia Pais, Serena Scala, Maria Rosa Lidonnici, Samantha Scaramuzza, Alessandra Albertini, Simona Esposito, Fabiola De Mattia, Daniele Canarutto, Francesca Tucci, Maryam Omrani, Francesca Dionisio, Stefania Giannelli, Sarah Marktel, Valeria Calbi, Francesca Ferrua, Bernhard Gentner, Fabio Ciceri, Luigi Naldini, Giuliana Ferrari, Alessandro Aiuti, Eugenio Montini
Journal: Blood (2022)
Platelet Count Threshold Associated with Bleeding in Adult Patients with Immune Thrombocytopenia Treated with Antiplatelet Drugs. Results from the Carmen-France Registry
Authors: Natacha Ollier, Marie-Léa Piel-Julian, Matthieu Mahevas, Jean-Francois Viallard, Thibault Comont, Stéphane Chèze, Sylvain Audia, Mikael Ebbo, Louis Terriou, Jean-Christophe Lega, Pierre-Yves Jeandel, Bernard Bonnotte, Marc Michel, Maryse Lapeyre-Mestre, Bertrand Godeau, Guillaume Moulis
Journal: Blood (2022)
Hematopoietic and Immunological Assessment in Fanconi Anemia after <i>Ex Vivo</i> Lentiviral FANCA Gene Therapy with RP-L102
Authors: Rofida Nofal, Yan Yi Chan, Sushmita Sen, Ulises Juarez Figueroa, Hana Willner, Matthias Felber, Mark Krampf, Supawat Thongthip, Grace Choi, Eileen Nicoletti, Jonathan D. Schwartz, Kenneth I. Weinberg, Alfredo Rodriguez, Rajni Agarwal, Maria Grazia Roncarolo, Agnieszka Czechowicz
Journal: Blood (2022)
A Dexamethasone Sparing-Regimen with Daratumumab and Lenalidomide in Frail Patients with Newly-Diagnosed Multiple Myeloma: Efficacy and Safety Analysis of the Phase 3 IFM2017-03 Trial
Authors: Salomon Manier, Jill Corre, Cyrille Hulin, Kamel Laribi, Carla Araujo, Gian-Matteo Pica, Cyrille Touzeau, Pascal Godmer, Bohrane Slama, Lionel Karlin, Frederique Orsini-Piocelle, Mamoun Dib, Margaret Macro, Laurence Sanhes, Aurore Perrot, Jean Yves Mary, Jerome Lambert, Herve Avet-Loiseau, Philippe Moreau, Xavier Leleu, Thierry Facon
Journal: Blood (2022)
A Phase II Study of Mini-Hyper-CVD Plus Inotuzumab Ozogamicin, with or without Blinatumomab, in Older Adults with Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia: Updated Results and Predictors for Outcomes
Authors: Patrice Nasnas, Elias Jabbour, Nicholas Short, Farhad Ravandi, Xuelin Huang, Nitin Jain, Tapan M. Kadia, Yesid Alvarado, Jan A. Burger, Naval Daver, Gautam Borthakur, Courtney D. DiNardo, Marina Konopleva, Guillermo Garcia-Manero, William G. Wierda, Jovitta Jacob, Wuliamatu Deen, Monica Kwari, Christopher Loiselle, Edith Roy, Anna Milton, Juan Rivera, Rebecca Garris, Hagop Kantarjian
Journal: Blood (2022)
A Fixed-Duration Immunochemotherapy Approach Combined with Ibrutinib in CLL Produces Deep and Sustained MRD Responses: 5.5-Year Results from the Icll-07 Filo Trial
Authors: Anne-Sophie Michallet, Rémi Letestu, Magali Le Garff-Tavernier, Carmen Aanaei, Michel Ticchioni, Marie-Sarah Dilhuydy, Stephane Morisset, Valérie Rouille, Béatrice Mahé, Kamel Laribi, Bruno Villemagne, Emmanuelle Ferrant, Olivier Tournilhac, Alain Delmer, Christelle Portois, Lysiane Molina, Véronique Leblond, Cécile Tomowiak, Sophie de Guibert, Frederique Orsini, Anne Banos, Philippe Carassou, Guillaume Cartron, Luc Mathieu Fornecker, Loic Ysebaert, Caroline Dartigeas, Margot Truchan, Jean-Pierre Vilque, Therese Aurran Schleinitz, Cymbalista Florence, Stéphane Leprêtre, Vincent Lévy, Florence Nguyen Khac, Pierre Feugier
Journal: Blood (2022)
Phase 1b/2a Study of AZD4573 (CDK9i) and Acalabrutinib in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (r/r DLBCL): Results from Dose-Escalation
Authors: Paolo Strati, Tae Min Kim, Alexey V Danilov, Chan Y. Cheah, Dok Hyun Yoon, Wojciech Jurczak, Shringi Sharma, Jeong Lim Yoon, Serena Arduini, Jamal Saeh, Richard F. Olsson, Gareth Gregory
Journal: Blood (2022)
Clinical Benefit Associated with Biomarker Changes Indicative of Disease Modification in Patients with Myelofibrosis Treated with the BET Inhibitor Pelabresib As Monotherapy or in Combination with Ruxolitinib
Authors: Joseph Scandura, Srdan Verstovsek, Marina Kremyanskaya, Moshe Talpaz, Raajit K Rampal, Alessandro Vannucchi, Vikas Gupta, Francesca Palandri, Andrea Patriarca, Prithviraj Bose, Dong Chen, Oksana Zavidij, Jike Cui, Tzuu-Wang Chang, Pietro Taverna, John Mascarenhas, Claire Harrison
Journal: Blood (2022)
Donor Selection Considering Donor Age in Hematopoietic Cell Transplant Recipients 50-75 Years of Age
Authors: Sachiko Seo, Junya Kanda, Kenta Kono, Yoshihiro Inamoto, Naoyuki Uchida, Noriko Doki, Masatsugu Tanaka, Masashi Sawa, Makoto Onizuka, Yuta Katayama, Tetsuya Eto, Ken-ichi Matsuoka, Takahiro Fukuda, Takahide Ara, Yukiyasu Ozawa, Toshiro Kawakita, Keisuke Kato, Koji Uchiyama, Tatsuo Ichinohe, Yoshiko Atsuta, Fumihiko Kimura
Journal: Blood (2022)
Splenectomy for Immune Cytopenias: Treatment Outcomes and Predictors of Response
Authors: Olisaemeka Ogbue, Waled Bahaj, Tariq Kewan, Ramsha Ahmed, Fauzia Ullah, Valeria Visconte, Sara Maskal, Carmelo Gurnari, Steven Rosenblatt, Jaroslaw P. Maciejewski
Journal: Blood (2022)
The Augmented Hematologist: Human-AI Feedback Loops to Assist Differential Cell Count during the Analysis of Bone Marrow Aspirates
Authors: David Bermejo-Peláez, Sandra Rueda Charro, Adriana Mousa, Elisa Alamo, Maria Garcia Roa, Roberto Trelles-Martínez, Marta Hidalgo Soto, Alejandro Bobes-Fernández, Roberto Garcia-Vicente, María Luz Morales, Alba Rodríguez García, Alejandra Ortiz-Ruiz, Alberto Blanco-Sánchez, Lin Lin, Elena Dacal, Rosa Ayala, Miguel Luengo-Oroz, María Linares, Joaquin Martinez Lopez
Journal: Blood (2022)
Comprehensive Characterization of Prolonged Unexplained Cytopenias in Relapsed/Refractory Multiple Myeloma Patients Following BCMA-Directed CAR-T Cell Therapy
Authors: Santiago Thibaud, Md. Babu Mia, Oliver Van Oekelen, Tarek H. Mouhieddine, Christoph Schaniel, Yogita Ghodke-Puranik, Adolfo Aleman, Bhaskar Upadhyaya, Guido Lancman, Alessandro Lagana, Shambavi Richard, Adriana Rossi, Ajai Chari, Larysa Sanchez, Cesar Rodriguez, Hearn J. Cho, Joshua Richter, Ronald Hoffman, Sundar Jagannath, Samir Parekh
Journal: Blood (2022)
A 3-Year Follow-up Comparison of Clinical Outcomes from Zuma-5 (Axicabtagene Ciloleucel) and the International Scholar-5 External Control Cohort in Relapsed/Refractory Follicular Lymphoma (R/R FL)
Authors: Paola Ghione, Maria Lia Palomba, Markqayne D. Ray, Eve H. Limbrick-Oldfield, Jess Owen, Steve Kanters, Sabela Bobillo, Maria Teresa Ribeiro, Caron A. Jacobson, Sattva S. Neelapu, Herve Ghesquieres, Myrna Nahas, Sara Beygi, Anik R. Patel, John G. Gribben
Journal: Blood (2022)
Safety and Efficacy of Tinostamustine in Pre-Treated Patients with Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL): Early Results from an Additional Expansion Cohort of a Phase I Study
Authors: Anna Sureda, Antonio Pinto, Herve Ghesquieres, Franck Morschhauser, Olivier Tournilhac, Pim Mutseaers, Josée M. Zijlstra, Floris A. De Jong, Tomas Janik, Pier Luigi Zinzani
Journal: Blood (2022)